<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01752972</url>
  </required_header>
  <id_info>
    <org_study_id>BSMMU-006-CT</org_study_id>
    <nct_id>NCT01752972</nct_id>
  </id_info>
  <brief_title>Effect of Spirulina on Zinc, Vitamin E and Linoleic Acid Levels in Palm Skin Following Chronic Exposure to Arsenic</brief_title>
  <official_title>Effect of Spirulina on the Levels of Zinc, Vitamin E and Linoleic Acid in the Palm Skin Extracts of People With Prolonged Exposure to Arsenic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients of arsenical keratosis may be treated with spirulina. Is this improvement related to
      the levels of zinc, vitamin E and linoleic acid at the site of the keratosis (palm)? To
      understand this, patients of palmer arsenical keratosis (n=10), arsenic exposed controls
      (n=10) and healthy volunteers (n=10) will be treated with spirulina powder 10 g/day orally
      for 12 weeks. Skin extracts will be collected both before and after supplementation from the
      palm and dorsum for estimation of zinc, vitamin E and linoleic acid levels.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients of arsenical keratosis remain untreated due to unavailability of effective drug. To
      find out an effective drug, the pathogenesis of keratosis should be understood. Spirulina is
      one of the dietary supplements, that improves the symptoms of keratosis. Is this improvement
      related to the levels of zinc, vitamin E and linoleic acid at the site of the keratosis
      (palm)? Ten patients of moderate palmer arsenical keratosis will be treated with spirulina
      powder 10 g/day orally for 12 weeks. Skin extracts will be collected both before and after
      supplementation from the palm and dorsum using a mixture of chloroform and ethanol. Zinc,
      vitamin E and linoleic acid levels will be estimated from the extracts. Similar protocol of
      spirulina administration and the collection of skin extracts will be done in arsenic exposed
      controls (n=10) and healthy volunteers (n=10).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in vitamin E levels in skin palm extract following supplementation with spirulina</measure>
    <time_frame>0 week (baseline), 12 weeks (end)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in zinc levels in skin palm extract following supplementation with spirulina</measure>
    <time_frame>0 week (baseline), 12 weeks (end)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in linoleic acid levels in skin palm extract following supplementation with spirulina</measure>
    <time_frame>0 week (baseline), 12 weeks (end)</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Arsenical Keratosis</condition>
  <arm_group>
    <arm_group_label>Palmer arsenical keratosis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Spirulina 10 g/day orally for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arsenic exposed controls</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Spirulina 10 g/day orally for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Heathy volunteers</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Spirulina 10 g/day orally for 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Spirulina</intervention_name>
    <description>10 g/day orally for 12 weeks</description>
    <arm_group_label>Palmer arsenical keratosis</arm_group_label>
    <arm_group_label>Arsenic exposed controls</arm_group_label>
    <arm_group_label>Heathy volunteers</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria (Patients):

          -  moderate palmer keratosis

          -  drink arsenic contaminated water (&gt;50 µg/L) for at least 6 months

          -  voluntarily agree to participate

        Inclusion Criteria (Arsenic exposed controls):

          -  no symptoms of keratosis

          -  family member of the patient

          -  drink arsenic contaminated water (&gt;50 µg/L) for at least 6 months

          -  voluntarily agree to participate

        Inclusion Criteria (Healthy volunteers):

          -  no symptoms of keratosis

          -  drink arsenic safe water (&lt;50 µg/L)

          -  voluntarily agree to participate

        Exclusion Criteria:

          -  pregnancy

          -  lactation

          -  chronic diseases: diabetes mellitus, rheumatoid arthritis, tuberculosis

          -  arsenicosis patients under treatment in the previous 3 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mir Misbahuddin, MBBS, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bangabandhu Sheikh Mujib Medical University</name>
      <address>
        <city>Dhaka</city>
        <country>Bangladesh</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bangladesh</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 17, 2012</study_first_submitted>
  <study_first_submitted_qc>December 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 19, 2012</study_first_posted>
  <last_update_submitted>December 17, 2012</last_update_submitted>
  <last_update_submitted_qc>December 17, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 19, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh</investigator_affiliation>
    <investigator_full_name>Prof. Mir Misbahuddin</investigator_full_name>
    <investigator_title>Prof. and Chairman</investigator_title>
  </responsible_party>
  <keyword>Arsenic</keyword>
  <keyword>Keratosis</keyword>
  <keyword>Linoleic acid</keyword>
  <keyword>Palm</keyword>
  <keyword>Spirulina</keyword>
  <keyword>Vitamin E</keyword>
  <keyword>Zinc</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratosis</mesh_term>
    <mesh_term>Keratosis, Actinic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin E</mesh_term>
    <mesh_term>Tocopherols</mesh_term>
    <mesh_term>Tocotrienols</mesh_term>
    <mesh_term>alpha-Tocopherol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

